References of "Henrotin, Yves"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailChitosan enriched three-dimensional matrix reduces inflammatory and catabolic mediators production by human chondrocytes
Oprenyeszk, Frédéric ULg; Sanchez, Christelle ULg; Dubuc, Jean-Emile et al

in PLoS ONE (2015), 10(5),

This in vitro study investigated the metabolism of human osteoarthritic (OA) chondrocytes encapsulated in a spherical matrix enriched of chitosan. Human OA chondrocytes were encapsulated and cultured for ... [more ▼]

This in vitro study investigated the metabolism of human osteoarthritic (OA) chondrocytes encapsulated in a spherical matrix enriched of chitosan. Human OA chondrocytes were encapsulated and cultured for 28 days either in chitosan-alginate beads or in alginate beads. The beads were formed by slowly passed dropwise either the chitosan 0.6%- alginate 1.2% or the alginate 1.2% solution through a syringe into a 102 mM CaCl2 solution. Beads were analyzed histologically after 28 days. Interleukin (IL)-6 and -8, prostaglandin (PG) E2, matrix metalloproteinases (MMPs), hyaluronan and aggrecan were quantified directly in the culture supernatant by specific ELISA and nitric oxide (NO) by using a colorimetric method based on the Griess reaction. Hematoxylin and eosin staining showed that chitosan was homogeneously distributed through the matrix and was in direct contact with chondrocytes. The production of IL-6, IL-8 and MMP-3 by chondrocytes significantly decreased in chitosan-alginate beads compared to alginate beads. PGE2 and NO decreased also significantly but only during the first three days of culture. Hyaluronan and aggrecan production tended to increase in chitosan-alginate beads after 28 days of culture. Chitosan-alginate beads reduced the production of inflammatory and catabolic mediators by OA chondrocytes and tended to stimulate the synthesis of cartilage matrix components. These particular effects indicate that chitosan-alginate beads are an interesting scaffold for chondrocytes encapsulation before transplantation to repair cartilage defects. [less ▲]

Detailed reference viewed: 18 (5 ULg)
Full Text
See detailPrevention of Synovial Membrane Inflammation & Cartilage Degradation by a Novel Chitosan
Henrotin, Yves ULg; Oprenyeszk, Frédéric ULg; Dubuc, Jean-Emile et al

Conference (2015, May 10)

Detailed reference viewed: 12 (1 ULg)
Full Text
Peer Reviewed
See detailDevelopment and evaluation in vitro and in vivo of injectable hydrolipidic gels with sustained-release properties for the management of articular pathologies such as osteoarthritis.
Réeff, Jonathan; Oprenyeszk, Frédéric ULg; Franck, Thierry ULg et al

in International Journal of Pharmaceutics (2015), 490

This study aimed to evaluate glycerol monooleate (GMO) as a carrier to develop viscoelastic and injectable sustained-release drug delivery systems. The potential pro- and antioxidant activity of the ... [more ▼]

This study aimed to evaluate glycerol monooleate (GMO) as a carrier to develop viscoelastic and injectable sustained-release drug delivery systems. The potential pro- and antioxidant activity of the developed hydrolipidic gels were evaluated by measuring the production of ROS by polymorphonuclear leukocytes (PMNs). In addition, the biocompatibility and effectiveness of two selected gel candidates were evaluated in vivo by evaluating the benefit of a single intraarticular injection of these new treatments in a model of osteoarthritis in rabbits. The in vitro study demonstrated that the carrier F1 did not have a pro-oxidative effect and even protected PMNs against natural auto-activation, regardless of the incorporation of either clonidine chlorhydrate or betamethasone dipropionate. The in vivo study demonstrated that F1 and F1-BDP induced a loss of cartilage quality in comparison to the control and reference groups but that the lesions of cartilage observed were generally mild, with not much full-depth erosion. Moreover, no exacerbating inflammation was observed when considering the synovial membranes and the PGE2 and CRP levels. These results seemed to demonstrate that the sustained-release formulation based on GMO could be well-tolerated after intraarticular injection. Moreover, it could have the potential to prevent inflammatory conditions while sustaining drug activity locally over weeks. [less ▲]

Detailed reference viewed: 10 (3 ULg)
Full Text
Peer Reviewed
See detailBaseline Fibulin3 concentrations are associated with incidence of clinical knee OA after 30 months in overweight and obese women
Runhaar, Jos; Sanchez, Christelle ULg; Henrotin, Yves ULg et al

in Osteoarthritis and Cartilage (2015, April), 23(S2), 83

Detailed reference viewed: 11 (0 ULg)
Full Text
Peer Reviewed
See detailANALGESIC EFFICACY AND SAFETY OF CURCUMINOIDS IN CLINICAL PRACTICE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Henrotin, Yves ULg; Sahebkar, A

in Osteoarthritis and Cartilage (2015), 23(S2), 356

Detailed reference viewed: 12 (0 ULg)
Full Text
Peer Reviewed
See detailOleuropein or rutin consumption decreases the spontaneous development of osteoarthritis in the Hartley guinea pig.
Horcajada, M.-N.; Sanchez, Christelle ULg; Membrez Scalfo et al

in Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society (2015), 23(1), 94-102

OBJECTIVE: To assess the potential protective effects of three polyphenols oleuropein, rutin and curcumin, on joint ageing and osteoarthritis (OA) development. DESIGN: Sixty 4-week-old Dunkin-Hartley ... [more ▼]

OBJECTIVE: To assess the potential protective effects of three polyphenols oleuropein, rutin and curcumin, on joint ageing and osteoarthritis (OA) development. DESIGN: Sixty 4-week-old Dunkin-Hartley guinea pigs were randomized into four groups and received daily during 31 weeks either standard guinea pig diet (control group) or a standard guinea pig diet enriched with oleuropein (0.025%), rutin (0.5%) or rutin/curcumin (0.5%/0.25%) association. Biomarkers of OA (Coll2-1, Coll2-1NO2, Fib3-1, Fib3-2, ARGS), as well as inflammation (PGE2) were quantified in the serum. Histological assessments of knee cartilage and synovial membrane were performed at week 4 (five young reference guinea pigs) and week 35. RESULTS: At week 35, guinea pigs in the control group spontaneously developed significant cartilage lesions with mild synovial inflammation. The histological scores of cartilage lesions and synovitis were well correlated with the increased level of serum biomarkers. Histologically, all treatments significantly reduced the cartilage degradation score (P < 0.01), but only oleuropein significantly decreased the synovial histological score (P < 0.05) and serum PGE2 levels (P < 0.01) compared to the control group. Coll2-1 was decreased by rutin and the combination of rutin/curcumin, Fib3-1 and Fib3-2 were only decreased by the rutin/curcumin mixture, while Coll2-1NO2 was significantly decreased by all treatments (P < 0.05). CONCLUSION: Oleuropein and rutin +/- curcumin significantly slowed down the progression of spontaneous OA lesions in guinea pigs. While no additive effect was seen in the curcumin + rutin group, the differential effects of oleuropein and rutin on inflammatory and cartilage catabolic markers suggest an interesting combination for future studies in OA protection. [less ▲]

Detailed reference viewed: 31 (5 ULg)
See detailJoint care composition
Serisier, Samuel; Comblain, Fanny ULg; Henrotin, Yves ULg

Patent (2014)

The present invention relates to a composition comprising curcuminoid with green tea polyphenol or with a combination of glycine, proline and hydroxyproline for use in preventing or treating ... [more ▼]

The present invention relates to a composition comprising curcuminoid with green tea polyphenol or with a combination of glycine, proline and hydroxyproline for use in preventing or treating osteoarthritis. It also relates to a method of preventing or treating osteoarthritis in mammals, the method comprising administering to said mammal a composition which comprises curcuminoid with green tea polyphenol or with a combination of glycine, proline and hydroxyproline. [less ▲]

Detailed reference viewed: 11 (2 ULg)
Full Text
See detailCell cultivation in chitosan alginate hydrogel beads
Henrotin, Yves ULg; Kesteloot, Frédéric; Sanchez, Christelle ULg

Patent (2014)

Detailed reference viewed: 16 (1 ULg)
Full Text
See detailBiomarker for osteoarthritis and/or other ageing-related diseases, and use thereof
Henrotin, Yves ULg; Gharbi, Myriam; DEBERG, Michelle ULg et al

Patent (2014)

Detailed reference viewed: 18 (8 ULg)
Full Text
Peer Reviewed
See detailBone sialoprotein as a potential key factor implicated in the pathophysiology of osteoarthritis
Pesesse, Laurence ULg; Sanchez, Christelle ULg; Walsh, David et al

in Osteoarthritis and Cartilage (2014), 22(4), 547-56

Detailed reference viewed: 13 (4 ULg)
Full Text
Peer Reviewed
See detailImportance of synovitis in osteoarthritis: Evidence for the use of glycosaminoglycans against synovial inflammation.
Henrotin, Yves ULg; Lambert, Cécile ULg; Richette, Pascal

in Seminars in Arthritis & Rheumatism (2014), 43(5), 579-87

Detailed reference viewed: 21 (3 ULg)
Full Text
Peer Reviewed
See detailOARSI guidelines for the non-surgical management of knee osteoarthritis
McAlindon; Henrotin, Yves ULg

in Osteoarthritis and Cartilage (2014), 22(3), 363-388

This paper presents concise, up-to-date, patient-focused, evidence-based, expert consensus guidelines for the management of knee osteoarthritis, intended to inform patients, physicians and allied ... [more ▼]

This paper presents concise, up-to-date, patient-focused, evidence-based, expert consensus guidelines for the management of knee osteoarthritis, intended to inform patients, physicians and allied healthcare professionnal worlwide. [less ▲]

Detailed reference viewed: 45 (1 ULg)
Full Text
Peer Reviewed
See detailTargeting the synovial angiogenesis as a novel treatment approach to osteoarthritis.
Henrotin, Yves ULg; Pesesse, Laurence; Lambert, Cécile ULg

in Therapeutic Advances in Musculoskeletal Disease (2014), 6(1), 20-34

Detailed reference viewed: 11 (0 ULg)
Full Text
Peer Reviewed
See detailWhat is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis?
Henrotin, Yves ULg; Marty, Marc; Mobasheri, Ali

in Maturitas (2014), 78

Chondroitin sulfate and glucosamine sulfate exert beneficial effects on the metabolism of in vitro models of cells derived from synovial joints: chondrocytes, synoviocytes and cells from subchondral bone ... [more ▼]

Chondroitin sulfate and glucosamine sulfate exert beneficial effects on the metabolism of in vitro models of cells derived from synovial joints: chondrocytes, synoviocytes and cells from subchondral bone, all of which are involved in osteoarthritis (OA). They increase type II collagen and proteoglycan synthesis in human articular chondrocytes and are able to reduce the production of some pro-inflammatory mediators and proteases, to reduce the cellular death process, and improve the anabolic/catabolic balance of the extracellular cartilage matrix (ECM). Clinical trials have reported a beneficial effect of chondroitin sulfate and glucosamine sulfate on pain and function. The structure-modifying effects of these compounds have been reported and analyzed in recent meta-analyses. The results for knee OA demonstrate a small but significant reduction in the rate of joint space narrowing. Chondroitin sulfate and glucosamine sulphate are recommended by several guidelines from international societies for the management of knee and hip OA, while others do not recommend these products or recommend only under condition. This comprehensive review clarifies the role of these compounds in the therapeutic arsenal for patients with knee OA [less ▲]

Detailed reference viewed: 32 (4 ULg)
Full Text
Peer Reviewed
See detailL'inhibition des voies de signalisation est-elle une possibilité thérapeutique pour l'arthrose?
Henrotin, Yves ULg

in Revue du Rhumatisme (2014)

Les voies de signalisation sont des cibles intéressantes pour les traitements de l’arthrose car leur inhibition ou leur activation permet de réguler l’expression d’un ensemble de gènes cibles directement ... [more ▼]

Les voies de signalisation sont des cibles intéressantes pour les traitements de l’arthrose car leur inhibition ou leur activation permet de réguler l’expression d’un ensemble de gènes cibles directement impliqués dans le dysfonctionnement métabolique des tissus articulaires. Cependant, les premiers essais cliniques réalisés dans la PR ont montré que la régulation spécifique de la voie JAK/STAT induit de nombreux effets secondaires. Ce point pourrait être un facteur limitant l’utilisation d’inhibiteurs ou d’activateurs spécifiques des voies de signalisation dans l’arthrose. Dans cette maladie, le rapport risque/bénéfice doit rester le facteur clé de la décision thérapeutique, car il s’agit de traiter une maladie d’évolution lente, de sévérité modérée et associée à de nombreuses comorbidités. [less ▲]

Detailed reference viewed: 24 (3 ULg)
Full Text
Peer Reviewed
See detailDoes signalling pathways inhibition hold therapeutic promise for osteoarthritis?
Henrotin, Yves ULg

in Joint Bone Spine (2014), 81

Signalling pathways inhibition hold promise as therapeutic targets in osteoarthritis but safety concern may limit their use to the more sevre form of the disease.

Detailed reference viewed: 18 (0 ULg)
Full Text
Peer Reviewed
See detailDecrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial.
Henrotin, Yves; Henrotin, Yves ULg

in BMC Complimentary & Alternative Medicine (2014)

The management of osteoarthritis (OA) remains a challenge. There is a need not only for safe and efficient treatments but also for accurate and reliable biomarkers that would help diagnosis and monitoring ... [more ▼]

The management of osteoarthritis (OA) remains a challenge. There is a need not only for safe and efficient treatments but also for accurate and reliable biomarkers that would help diagnosis and monitoring both disease activity and treatment efficacy. Curcumin is basically a spice that is known for its anti-inflammatory properties. In vitro studies suggest that curcumin could be beneficial for cartilage in OA. The aim of this exploratory, non-controlled clinical trial was to evaluate the effects of bio-optimized curcumin in knee OA patients on the serum levels of specific biomarkers of OA and on the evaluation of pain. This study highlighted the potential effect of curcumin in knee OA patient. This effect was reflected by the variation of a cartilage specific biomarker, Coll2-1 that was rapidly affected by the treatment. These results are encouraging for the qualification of Coll2-1 as a biomarker for the evaluation of curcumin in OA treatment. (Trial registration: NCT01909037 at clinicaltrials.gov) [less ▲]

Detailed reference viewed: 34 (2 ULg)